Brexit Could Affect Europe’s Ability To Respond To Public Health Emergencies, Pharmaceutical Industry Report Says

Financial Times: Pharma warning of Brexit impact to public health emergencies
“U.K. pharma industry leaders have warned of the potential impact of Brexit on Europe’s capacity to respond to a continent-wide public health emergency, as they step up their drive to ensure the sector’s interests are addressed when the next phase of negotiations begins. The Association of the British Pharmaceutical Industry and the BioIndustry Association said that Europe’s ability to manage big public health crises related to the use of medicines, such as the Zika virus, could be at risk if the U.K. were excluded from cross-E.U. incident management planning…” (Neville, 12/12).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.